• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, July 14, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

UMN Medical School’s Center for Magnetic Resonance Research receives NIH U01 grant

Bioengineer by Bioengineer
September 29, 2017
in Biology
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

The University of Minnesota Medical School's Center for Magnetic Resonance Research (CMRR) has been awarded a grant from the National Institutes of Health's BRAIN Initiative. The project will develop new, efficient and safe stimulation paradigms for Deep Brain Stimulation (DBS), which is used to treat common symptoms of neurological disorders including Parkinson's Disease.

"Our work has the potential to revolutionize neuromodulation strategies by increasing the precision with which the technology can target specific pathways in the brain," says principal investigator Shalom Michaeli, Ph.D. The novel DBS system, he says, can be configured not only to generate unidirectional fields for orientation-selective stimulation but also to produce rotating electrical field gradients for modulation of neuronal activity regardless of axon orientations.

The grant is part of an NIH BRAIN Initiative program, "New Technologies and Novel Approaches for Large-Scale Recording and Modulation in the Nervous System (U01)," which has awarded a total of $3.5 million over three years to the research teams with the University of Minnesota, Columbia University and the A.I. Virtanen Institute at the University of Eastern Finland.

"This work is critical for addressing the shortcomings in current DBS technology," says Dr. Michaeli. "By furthering our understanding of DBS mechanisms in humans we can potentially improve treatment quality for patients with disabling neurological symptoms."

Collaborating research teams within the University of Minnesota include the CMRR (S. Michaeli, S. Mangia, D. Idiyatullin and L. Lehto), Department of Neurosurgery (W. Low), Department of Neurology (G. Molnar), and the Department of Biomedical Engineering (M. Johnson). University of Minnesota researchers will combine expertise with their colleagues from Columbia University (Dr. K. Shepard, Electrical Engineering) and A.I. Virtanen Institute, Finland (Drs. O. Gröhn and H. Tanila).

NIH Grant Number: 1U01NS103569-01

###

Media Contact

Naomi McDonald
[email protected]
612-301-9525

https://www.med.umn.edu/

Share12Tweet8Share2ShareShareShare2

Related Posts

Enhancing bacteria to accelerate environmental cleanup processes

Enhancing bacteria to accelerate environmental cleanup processes

July 14, 2026
New Insights into Immune Checkpoints’ Role in Controlling Inflammation

New Insights into Immune Checkpoints’ Role in Controlling Inflammation

July 14, 2026

UMA Scientists Enhance Morphine’s Pain-Relief Effectiveness

July 14, 2026

Adolescent Brain Responses to Faces Could Forecast Social Development

July 13, 2026
Please login to join discussion

POPULAR NEWS

  • New Drug Candidate Developed at McMaster Shows Potential for Treating Brain Cancer

    58 shares
    Share 23 Tweet 15
  • Detection of EDCs in Breast Milk and Infant Urine Up to Six Months Highlights Early Exposure Risks

    77 shares
    Share 31 Tweet 19
  • Experimental Therapy Simultaneously Destroys Prostate Tumor Cells and Reactivates Antitumor Immunity

    46 shares
    Share 18 Tweet 12
  • 高齢者の骨粗鬆症治療の持続性比較

    51 shares
    Share 20 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Sensitive SWCNT Pyroelectric Phototransistors for Broadband Infrared Detection at Room Temperature

Engineering Principles Advance Battery Electrolyte Design for Better Performance

Nonlinear Dynamics of Cube Net Cage in Jacket Foundation at Different Depths

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 85 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.